Chau Q. Khuong

Insider Reports History

Entity
Individual
Location
C/O Orbimed Advisors, 601 Lexington Avenue, 54 Th Floor, New York, NY
Signature
/s/ Steven P. Cobourn, as attorney-in fact for Chau Q. Khuong
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Chau Q. Khuong:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Galecto, Inc. Director Stock Option (right to buy) 18K Jun 14, 2023 Direct
Fusion Pharmaceuticals Inc. Director Stock Option (Right to Buy) 17K Jun 14, 2023 Direct
NextCure, Inc. Director Stock Option (Right to Buy) 14.3K Jun 22, 2023 Direct

Insider Reports Filed by Chau Q. Khuong

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NXTC NextCure, Inc. Jun 22, 2023 1 $0 4 Jun 23, 2023 Director
GLTO Galecto, Inc. Jun 14, 2023 1 $0 4 Jun 15, 2023 Director
FUSN Fusion Pharmaceuticals Inc. Jun 14, 2023 1 $0 4 Jun 14, 2023 Director
FUSN Fusion Pharmaceuticals Inc. Nov 11, 2022 1 $100K 4 Nov 14, 2022 Director
NXTC NextCure, Inc. Jun 23, 2022 1 $0 4 Jun 24, 2022 Director
FUSN Fusion Pharmaceuticals Inc. Jun 14, 2022 1 $0 4 Jun 22, 2022 Director
GLTO Galecto, Inc. Jun 14, 2022 1 $0 4 Jun 15, 2022 Director
GLTO Galecto, Inc. Nov 17, 2021 1 $0 4 Nov 19, 2021 Director
NXTC NextCure, Inc. Jun 24, 2021 1 $0 4 Jun 28, 2021 Director
FUSN Fusion Pharmaceuticals Inc. Jun 4, 2021 1 $0 4 Jun 7, 2021 Director
GLTO Galecto, Inc. May 26, 2021 1 $0 4 May 28, 2021 Director